TY - JOUR T1 - Dissecting conformational rearrangements and allosteric modulation in metabotropic glutamate receptor activation JF - bioRxiv DO - 10.1101/2022.01.07.474531 SP - 2022.01.07.474531 AU - Nathalie Lecat-Guillet AU - Robert B. Quast AU - Hongkang Liu AU - Thor C. Møller AU - Xavier Rovira AU - Stéphanie Soldevila AU - Laurent Lamarque AU - Eric Trinquet AU - Jianfeng Liu AU - Jean-Philippe Pin AU - Philippe Rondard AU - Emmanuel Margeat Y1 - 2022/01/01 UR - http://biorxiv.org/content/early/2022/01/08/2022.01.07.474531.abstract N2 - Selective allosteric modulators bear great potential to fine-tune neurotransmitter-induced brain receptor responses. Promising targets are metabotropic glutamate (mGlu) receptors, which are associated to different brain diseases. These multidomain class C GPCRs experience concerted structural rearrangements and rely on allosteric modulation of agonist action to be fully activated. Here we establish live cell compatible fluorescence labeling of mGlu2 by click chemistry through genetic code expansion. Using lanthanide resonance energy transfer, we establish multiple FRET sensors to monitor ligand effects on conformational changes in mGlu2 extracellular domain and subsequently dissect the underlying conformational states by smFRET. Using three distinct FRET sensors, we demonstrate that mGlu activation relies on a ligand-induced sampling of three conformational states. Orthosteric agonists act by promoting the closure of the mGlu2 ligand binding domains, leading to an equilibrium between an inactive intermediate and the active state. Allosteric modulator further push this equilibrium toward the active state, promoting and stabilizing the relative reorientation of the mGlu protomers. These results underline the complex and dynamic nature of such type of neuroreceptors, pointing out that ligands fine-tune activation by differentially acting on the equilibria between multiple states.Competing Interest StatementThe authors have declared no competing interest. ER -